Zarxio

Active Ingredient(s): Filgrastim-sndz
FDA Approved: * March 6, 2015
Pharm Company: * SANDOZ INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zarxio Overview

Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low blood neutrophils.[1] This may occur following chemotherapy, radiation poisoning, HIV/AIDS, or unknown cause.[1] It may also be used to increase white blood cells for gathering during leukapheresis.[1] It is given either by injection into a vein or under the skin.[1] Common side effects include fever, cough, chest pain, joint pain, vomi...

Read more Zarxio Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Filgrastim

Recent Zarxio Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Filgrastim-sndz
  • Injection: 300 Mcg/0.5 Ml, 300mcg/0.5ml, 300mcg/ml, 480 Mcg/0.8 Ml, 480mcg/0.8ml, 480mcg/1.6ml
  • Syringe: 300mgc/0.5ml, 300ug/0.5ml, 480, 480mcg/0.8ml
  • Vial: 300mcg/1ml, 300ug/ml, 480, 480mcg/1.6ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zarxio: (4 results)

Sorted by National Drug Code
  • 61314-304 Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
  • 61314-312 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
  • 61314-318 Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.
  • 61314-326 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.

Other drugs which contain Filgrastim-sndz or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA